Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study

Authors: Lordick, F. ^{1, ∗}, Mauer, M.E. ², Stocker, G. ¹, Cella, C.A. ³, Ben-Aharon, I. ⁴, Piessen, G. ⁵, Wyrwicz, L. ⁶, Al-Haidari, G. ⁷, Fleitas-Kanonnikoff, T. ⁸, Boige, V. ⁹, Lordick Obermannová, R. ¹⁰, Martens, U.M. ¹¹, Gomez-Martin, C. ¹², Thuss-Patience, P. ¹³, Arrazubi, V. ¹⁴, Avallone, A. ¹⁵, Shiu, K.K. ¹⁶, Artru, P. ¹⁷, Brenner, B. ¹⁸, Buges Sanchez, C. ¹⁹, Chau, I. ²⁰, Lorenzen, S. ²¹, Daum, S. ²², Sinn, M. ²³, Merelli, B. ²⁴, van Grieken, N.C.T. ²⁵, Nilsson, M. ^{26, 27}, Collienne, M. ², Giraut, A. ², Smyth, E. ²⁸

Source: In Annals of Oncology February 2025 36(2):197-207

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

Authors: Algeri, L., Falkman, L., Spada, F., Frassoni, S., Bagnardi, V., Boselli, S., Cardinale, D., Zanobini, M., Crona, J., Benini, L., Tamayo, D., Mazzon, C., Gervaso, L., Cella, C.A., Zampino, M.G., Ciardiello, D., Russo, A., Badalamenti, G., Welin, S., Fazio, N.

Source: In ESMO Open November 2024 9(11)

Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study

Authors: Guidi, L. ^{1, 2, †}, Valenza, C. ^{1, 2, †}, Battaiotto, E. ^{1, 2}, Trapani, D. ^{1, 2}, Ghioni, M.C. ³, Crimini, E. ^{1, 2}, Boscolo Bielo, L. ^{1, 2}, Venetis, K. ³, Belli, C. ¹, Bottiglieri, L. ³, Gervaso, L. ⁴, Cella, C.A. ⁴, Ciardiello, D. ⁴, Spada, F. ⁴, Benini, L. ⁴, Adorisio, R. ³, Mane, E. ³, Fazio, N. ⁴, Guerini Rocco, E. ³, Curigliano, G. ^{1, 2, ∗}, Zampino, M.G. ^{4, †}

Source: In ESMO Open August 2024 9(8)

Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape

Authors: Cella, C.A., Ciardiello, D., Gervaso, L., van Laarhoven, H., Nezi, L., Catozzi, C., Lordick, F., Smyth, E., de Pascale, S., Benini, L., Valenza, C., Guidi, L., Fumagalli Romario, U., Fazio, N.

Source: In ESMO Gastrointestinal Oncology June 2024 4

Promising targetable biomarkers in pancreatic neuroendocrine tumours

Authors: Borghesani, M., Gervaso, L., Cella, C.A., Benini, L., Ciardiello, D., Algeri, L., Ferrero, A., Valenza, C., Guidi, L., Zampino, MG., Spada, F., Fazio, N.

Source: Expert review of endocrinology & metabolism. 18(5):387-398

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194131316.0x000001&indx=1&recIds=ETOCvdc_100194131316.0x000001

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

Authors: Rubino, M., Scoazec, J.Y., Pisa, E., Faron, M., Spaggiari, L., Hadoux, J., Spada, F., Planchard, D., Cella, C.A., Leboulleux, S., De Marinis, F., Ducreux, M., Lamartina, L., Baudin, E. ^**, Fazio, N. ^*

Source: In Lung Cancer October 2020 148:149-158

Treatments for colorectal liver metastases: A new focus on a familiar concept

Authors: Zampino, M.G., Magni, E., Ravenda, P.S., Cella, C.A., Bonomo, G., Della Vigna, P., Galdy, S., Spada, F., Varano, G.M., Mauri, G., Fazio, N., Orsi, F.

Source: In Critical Reviews in Oncology / Hematology December 2016 108:154-163

PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms

Authors: Gervaso, L., Laffi, A., Meneses-Medina, M.I., Cella, C.A., Rubino, M., Pellicori, S., Spada, F., Fazio, N.

Source: Thrombosis research. 213(S2):S19-S20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100163859583.0x000001&indx=1&recIds=ETOCvdc_100163859583.0x000001

TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms

Authors: Gervaso, L., Laffi, A., Meneses-Medina, M.I., Cella, C.A., Rubino, M., Pellicori, S., Spada, F., Fazio, N.

Source: Thrombosis research. 213(S2):S19-S20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100163553032.0x000001&indx=1&recIds=ETOCvdc_100163553032.0x000001

1160P An Italian multicenter phase II trial of metronomic temozolomide in unfit patients with advanced neuroendocrine neoplasms: Interim analysis of the MeTe study

Authors: Spada, F., Jemos, C., Barberis, M., Pisa, E., Bagnardi, V., Frassoni, S., Boselli, S., Mazzon, C., Tamayo, D., Malengo, D., Omodeo Salè, E., Rossi, M., Gelsomino, F., Pusceddu, S., Benini, L., Cella, C.A., Ciardiello, D., Zampino, M.G., Gervaso, L., Fazio, N.

Source: In Annals of Oncology September 2024 35 Supplement 2:S757-S757

1159P Molecular characterization of extra-pulmonary mixed adeno-neuroendocrine carcinomas: The NIRVANA substudy

Authors: Spada, F., Pisa, E., Ranghiero, A., Frassoni, S., Bagnardi, V., Gervaso, L., Tamayo, D., Mazzon, C., Benini, L., Cella, C.A., Ciardiello, D., Fazio, N.

Source: In Annals of Oncology September 2024 35 Supplement 2:S757-S757

Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor

Authors: Moretto, R., Cella, C.A., Raimondo, L., Formisano, L., Nappi, L., Rescigno, P., Buonerba, C., Calabrese, F., Ottaviano, M., Di Lorenzo, G.

Source: ANTICANCER DRUGS. 24(7):759-764

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN357075784&indx=1&recIds=ETOCRN357075784

2293P Protumoral role of neutrophils and neutrophils extracellular traps (NETS) in non-metastatic gastroesophageal and rectal cancers

Authors: Catozzi, C., Gervaso, L., Benini, L., Ciardiello, D., Zampino, M.G., Spada, F., Borghesani, M., Valenza, C., Algeri, L., Guidi, L., Pellizzari, G., Fazio, N., Nezi, L., Cella, C.A.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1174-S1174

2148P Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors

Authors: Gervaso, L., Valenza, C., Mongillo, M., Boldrini, L., Bielo, L. Boscolo, Castellano, G., Guidi, L., Katrini, J., Nicolo, E., Pellizzari, G., Trapani, D., Cella, C.A., Lorenzetti, I.T., Derio, S., La Presa, M.T., Parma, G., Fazio, N., Curigliano, G., Khorana, A.A., Colombo, N.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1118-S1119

1670MO Validation of a new risk-assessment model for prediction of venous thromboembolism in cancer outpatients: The ONKOTEV score

Authors: Cella, C.A., Knoedler, M., Hall, M., Pellicori, S., Gervaso, L., Schorling, R., Bagnardi, V., Lordick, F., Fazio, N.

Source: In Annals of Oncology September 2021 32 Supplement 5:S1174-S1174

High-risk human papillomavirus in anal squamous cell carcinoma: a ‘conservative’ leading role

Authors: Ravenda, P.S., Zampino, M.G., Guerini-Rocco, E., Chiocca, S., Dell’Acqua, V., Trovato, C., Biffi, R., Ribero, D., Spada, F., Cella, C.A., Fazio, N.

Source: In Annals of Oncology May 2017 28(5):1160-1160

2344 Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus

Authors: Cella, C.A., Spada, F., Galdy, S., Frezza, A.M., Catapano, M., Funicelli, L., Calleri, A., Zorzino, L., Mancuso, P., Radice, D., Fazio, N.

Source: European journal of cancer. 51:S449-S449

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100031122289.0x000001&indx=1&recIds=ETOCvdc_100031122289.0x000001

1507TiP - Validation of a risk-assessment score for prediction of venous thromboembolism in cancer outpatients receiving active treatments: ONKOTEV-2 trial

Authors: Cella, C.A., Lordick, F., Fazio, N.

Source: In Annals of Oncology 1 October 2016 27 Supplement 6:vi521-vi521

703P - HER2/HER3 pathway in biliary tract cancers: A systematic review and meta-analysis. A novel therapeutic druggable target?

Authors: Galdy, S., Lamarca, A., McNamara, M., Hubner, R., Cella, C.A., Fazio, N., Valle, J.W.

Source: In Annals of Oncology 1 October 2016 27 Supplement 6:vi237-vi237

B16 - HER2/HER3 pathway in biliary tract cancers: a systematic review and meta-analysis. A novel therapeutic druggable target?

Authors: Galdy, S., Lamarca, A., McNamara, M., Hubner, R., Cella, C.A., Fazio, N., Valle, J.W.

Source: In Annals of Oncology September 2016 27 Supplement 4:iv22-iv22